In June 2025, the EMAs safety division, the Pharmacovigilance Risk Assessment Committee (PRAC), concluded a review of GLP-1 medication and its risk of patients developing NAION
This suggested that the PI3K/AKT pathway is increased in Gclc -deficient FoB, and in turn can sustain increased mTORC1 activity
In that case, diet, sleep, and gut-brain work often come first
The safety profile of oral semaglutide is similar to injectables, with the most common adverse events being gastrointestinal side effects like nausea, diarrhea, and constipation
Polymorphisms in the MTHFR gene influence embryo viability and the incidence of aneuploidy
Adjusting Dosage for Different Goals Your ideal compounded semaglutide with B12 dosage depends on your weight loss goals, tolerance, and how your body responds to the medication